Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Reich

Showing results (281-290 of 316) with videos related to

Pageof 32
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2023
Chronic prurigo: Insufficient disease control in spite of high healthcare usageManuel P Pereira, Elke Weisshaar, Jon Anders Halvorsen, et al.
The Journal of Allergy and Clinical Immunology|February 20, 2025
IL-36-driven pustulosis: Transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP)Theresa Benezeder, Natalie Bordag, Johannes Woltsche, et al.
Allergy|December 8, 2025
Long-Term Efficacy and Safety of Ligelizumab as Re-Treatment in Patients With Chronic Spontaneous UrticariaAna M Gimenez-Arnau, Marcus Maurer, Adam Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 20, 2024
Exploring shared clinical features and successful therapeutic interventions in CARD14-associated papulosquamous eruptionS Vanya J Rossel, Adam Reich, Avital Baniel, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2023
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III StudyKim A Papp, Mark G Lebwohl, Diamant Thaçi, et al.
NEJM Evidence|April 28, 2026
Efficacy and Safety of Imsidolimab for Generalized Pustular PsoriasisSandra Smieszek, Bartlomiej Przychodzen, Christina Tyner, et al.
Frontiers in Medicine|May 14, 2024
Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panelLidia Rudnicka, Magdalena Trzeciak, Erkan Alpsoy, et al.
Acta Dermato-Venereologica|August 11, 2017
Determinants of Psychosocial Health in Psoriatic Patients: A Multi-national StudyKarolina Lesner, Adam Reich, Jacek C Szepietowski, et al.
Postepy Dermatologii I Alergologii|June 4, 2020
Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part II. Systemic treatment and new therapeutic methodsRoman J Nowicki, Magdalena Trzeciak, Maciej Kaczmarski, et al.
Medycyna Wieku Rozwojowego|March 2, 2005
[Malignant vascular tumours in children -- report from the Polish Pediatric Rare Tumors Study]Ewa Bień, Jan Godziński, Anna Balcerska, et al.
Pageof 32

Showing results (281-290 of 316) with videos related to

Sort By:
Pageof 32
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2023
Chronic prurigo: Insufficient disease control in spite of high healthcare usageManuel P Pereira, Elke Weisshaar, Jon Anders Halvorsen, et al.
The Journal of Allergy and Clinical Immunology|February 20, 2025
IL-36-driven pustulosis: Transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP)Theresa Benezeder, Natalie Bordag, Johannes Woltsche, et al.
Allergy|December 8, 2025
Long-Term Efficacy and Safety of Ligelizumab as Re-Treatment in Patients With Chronic Spontaneous UrticariaAna M Gimenez-Arnau, Marcus Maurer, Adam Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 20, 2024
Exploring shared clinical features and successful therapeutic interventions in CARD14-associated papulosquamous eruptionS Vanya J Rossel, Adam Reich, Avital Baniel, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2023
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III StudyKim A Papp, Mark G Lebwohl, Diamant Thaçi, et al.
NEJM Evidence|April 28, 2026
Efficacy and Safety of Imsidolimab for Generalized Pustular PsoriasisSandra Smieszek, Bartlomiej Przychodzen, Christina Tyner, et al.
Frontiers in Medicine|May 14, 2024
Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panelLidia Rudnicka, Magdalena Trzeciak, Erkan Alpsoy, et al.
Acta Dermato-Venereologica|August 11, 2017
Determinants of Psychosocial Health in Psoriatic Patients: A Multi-national StudyKarolina Lesner, Adam Reich, Jacek C Szepietowski, et al.
Postepy Dermatologii I Alergologii|June 4, 2020
Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part II. Systemic treatment and new therapeutic methodsRoman J Nowicki, Magdalena Trzeciak, Maciej Kaczmarski, et al.
Medycyna Wieku Rozwojowego|March 2, 2005
[Malignant vascular tumours in children -- report from the Polish Pediatric Rare Tumors Study]Ewa Bień, Jan Godziński, Anna Balcerska, et al.
Pageof 32